16 completed, 2 recruiting, 2 unknown, 1 active not recruiting. 6 Phase 4, 3 Not applicable, 2 Phase 1, 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 5, Active not recruiting 1 |
| Not applicable | 3 | Completed 1, Recruiting 1, Suspended 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
Follow Intra-Abdominal Infection: new trials by email Literature Review of Intra-Abdominal Infection trials Research Report on Intra-Abdominal Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rezafungin Peritoneal Diffusion for Intra-abdominal Candidiasis Intra-Abdominal Infection, Candida | Completed | Central Hospital, Nancy, France | 18 | 2025-11-14 | 2026-10-02 | |
| Innate Immune Response Monitoring Via Monocyte HLA-DR in Severe Intra-abdominal Infections at Risk of Fungal Infection Immunomonitoring - Intra-abdominal Infection, Critical Illness | Recruiting | Central Hospital, Nancy, France | 100 | 2025-11-14 | 2026-02-09 | |
| Diagnostic Performance of the CandID PLUS PCR for the Diagnosis of Intra-abdominal Candidiasis in Critically Ill Patients Intra-Abdominal Infection, Candida | Completed | Central Hospital, Nancy, France | 88 | 2025-04-17 | 2025-06-05 | |
| Performance of the SeptiCyte LAB Test for Antibiotic Stewardship in Mesenteric Ischemia Septicyte Lab Test pre operative, Septicyte Lab Test post operative - Acute Mesenteric Ischemia, Sepsis Bacterial | Completed | Central Hospital, Nancy, France | 15 | 2024-08-01 | 2025-04-02 | |
| The Effect of Continuous Intravenous Infusion of Lidocaine on PPCs and Prognosis in Emergency Surgical Patients With IAI Lidocaine, Placebo - Postoperative Pulmonary Complications, Intra-abdominal Infection | Not applicable | Recruiting | Shanghai Zhongshan Hospital | 428 | 2023-10-31 | 2026-04-29 |
| Hellenic Registry for cIAIs (HERCO-II) Intra-abdominal Infection | Completed | Maximos Frountzas | 300 | 2022-10-01 | 2023-12-28 | |
| The PASTDUe Nutrition Ecosystem Project (PASTDUe) Nutrition Ecosystem pathway, Comparator - Diet, Healthy, Food | Phase 4 | Active not recruiting | Duke University | 300 | 2022-04-25 | 2026-04-23 |
| Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults Zavicefta, Ceftazidime-Avibactam, Best Available Treatment - Urinary Tract Infection, Acute Pyelonephritis | Phase 4 | Completed | Pfizer | 60 | 2021-08-26 | 2024-10-21 |
| Study for Rapid Diagnosis of Postoperative Abdominal Infection Postoperative Infection, Abdominal Surgery | Unknown | Peking Union Medical College Hospital | 30 | 2021-08-10 | 2022-09-15 | |
| The Optimization of a Low-dose CT Protocol in Patients With Suspected Uncomplicated Acute Appendicitis and BMI >30 Low-dose CT, Laparoscopic appendectomy - Appendicitis, Other and Unspecified Acute Appendicitis | Not applicable | Suspended | Turku University Hospital | 30 | 2020-11-04 | 2022-02-25 |
| Development of Risk Score Model and Decision Tree Algorithm for Predicting Infections With CRKp in Colonized Patients Detection of CRKp colonization - Bloodstream Infection, Pneumonia, Bacterial | Unknown | SCARE (Study group for carbapenem resistance) | 520 | 2020-04-01 | 2020-01-18 | |
| Study of Ceftolozane/Tazobactam (MK-7625A) in Combination With Metronidazole in Japanese Participants With Complicated Intra-abdominal Infection (MK-7625A-013) MK-7625A 1.5 g (ceftolozane 1 g/tazobactam 0.5 g), metronidazole 500 mg - Intra-abdominal Infection, Complicated Intra-abdominal Infection | Phase 3 | Completed | Merck Sharp & Dohme LLC | 100 | 2016-04-08 | 2018-08-09 |
| The Optimization of a Low-dose Computed Tomography Protocol in Patients With Suspected Uncomplicated Acute Appendicitis Low-dose CT, Laparoscopic appendectomy - Appendicitis, Other and Unspecified Acute Appendicitis | Not applicable | Completed | Turku University Hospital | 60 | 2015-07-01 | 2020-11-12 |
| A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection Tigecycline, Imipenem/cilastatin - Intra-abdominal Infection | Phase 4 | Completed | Pfizer | 470 | 2012-11-01 | 2018-04-09 |
| A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections moxifloxacin, ampicillin/sulbactam - Intra-abdominal Infection | Phase 4 | Completed | Kaohsiung Medical University Chung-Ho Memorial Hospital | 100 | 2009-01-01 | 2011-08-02 |
| Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections meropenem - Necrotizing Enterocolitis, Intra-abdominal Infection | Phase 1 / Phase 2 | Completed | The Emmes Company, LLC | 200 | 2008-06-01 | 2023-04-25 |
| T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam Ertapenem, Ampicillin-Sulbactam - Intra-Abdominal Infection | Phase 4 | Completed | University of Bologna | 142 | 2008-01-01 | 2011-08-18 |
| Autologous Fibrin Glues for Fistulas Closure Autologous platelet-rich fibrin glue (PRFG), Octreotide - Enterocutaneous Fistulas, Intra-abdominal Infection | Phase 1 | Completed | Jinling Hospital, China | 122 | 2008-01-01 | 2013-02-26 |
| Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age Tygacil - Bacterial Infections, Intra-Abdominal Infection | Phase 2 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 59 | 2007-12-01 | 2012-10-24 |
| Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI) tigecycline, ceftriaxone plus metronidazole - Appendicitis, Cholecystitis | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 473 | 2005-10-01 | 2013-02-25 |
Showing 20 of 22. Sign in to see all of them.
Intraabdominal Infections (22) · Sepsis (4) · Appendicitis (3) · Acute Disease (2) · Gastrointestinal Diseases (2) · Peritonitis (2) · Pneumonia, Bacterial (2) · Torulopsis (2) · Urinary Tract Infections (2) · Abdominal Abscess (1) · Abdominal Injuries (1) · Abscess (1) · Bacteremia (1) · Bacterial Infections (1) · Central Nervous System Infections (1)
Infections (21) · Pathological Conditions, Signs and Symptoms (9) · Pathologic Processes (8) · Digestive System Diseases (6) · Inflammation (6) · Intestinal Diseases (5) · Systemic Inflammatory Response Syndrome (5) · Disease Attributes (4) · Gastroenteritis (4) · Bacterial Infections and Mycoses (3) · Cecal Diseases (3) · Gastrointestinal Diseases (3) · Lung Diseases (3) · Pneumonia (3) · Respiratory Tract Diseases (3)
Tigecycline (3) · Ertapenem (2) · Metronidazole (2) · sultamicillin (2) · Ceftriaxone (1) · Cilastatin, Imipenem Drug Combination (1) · Duration of Therapy (1) · Lidocaine (1) · Meropenem (1) · Moxifloxacin (1) · Octreotide (1) · Tazobactam (1) · avibactam, ceftazidime drug combination (1) · ceftolozane (1) · lactitol (1)
Central Hospital, Nancy, France (4) · Wyeth is now a wholly owned subsidiary of Pfizer (3) · Merck Sharp & Dohme LLC (2) · Pfizer (2) · Turku University Hospital (2) · Duke University (1) · Jinling Hospital, China (1) · Kaohsiung Medical University Chung-Ho Memorial Hospital (1) · Maximos Frountzas (1) · Peking Union Medical College Hospital (1) · SCARE (Study group for carbapenem resistance) (1) · Shanghai Zhongshan Hospital (1) · The Emmes Company, LLC (1) · University of Bologna (1)
China (6) · France (5) · Finland (3) · Taiwan (3) · United States (3) · Greece (2) · Italy (2) · South Africa (2) · Turkey (Türkiye) (2) · Australia (1) · Belgium (1) · Denmark (1) · Germany (1) · Hong Kong (1) · India (1)
Paulina Salminen, MD, PhD (2) · Abdullah T Aslan, Dr. (1) · Antonio Daniele Pinna, MD (1) · Cristina Puggioli, MD (1) · Danny Benjamin, MD, PhD, MPH (1) · Fausto Catena, MD PhD (1) · Giorgio Ercolani, MD (1) · Konstantinos G Toutouzas, MD PhD (1) · Luca Ansaloni, MD (1) · Paul Wischmeyer (1) · Salomone Di Saverio, M.D. (1)
PMID 21501482, PMID 22249106, PMID 22439781, PMID 22955430, PMID 23631512, PMID 24183344, PMID 30528561, PMID 30584308, PMID 37288562, PMID 40913503, PMID 42829121